Skip to content
GenoLensGenoLens

MTHFR

Chr 1p36.22

methylenetetrahydrofolate reductase

MANE:
ENST00000376590.9

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Adult onset leukodystrophy

    BIALLELIC, autosomal or pseudoautosomal
  • Cerebral folate deficiency

    BIALLELIC, autosomal or pseudoautosomal
  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Early onset or syndromic epilepsy

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Undiagnosed metabolic disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Childhood onset dystonia, chorea or related movement disorder

+5 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • homocystinuria due to methylene tetrahydrofolate reductase deficiency

    0.86
  • schizophrenia

    0.66
  • neural tube defects, folate-sensitive

    0.57
  • thrombophilia due to thrombin defect

    0.54
  • Global developmental delay

    0.42
  • Bilateral tonic-clonic seizure

    0.42
  • ischemic stroke

    0.40
  • isolated spina bifida

    0.38
  • Seizure

    0.37
  • Abnormality of metabolism/homeostasis

    0.34

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Methylenetetrahydrofolate reductase (NADPH)

Catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a cosubstrate for homocysteine remethylation to methionine (PubMed:29891918). Represents a key regulatory connection between the folate and methionine cycles (Probable)

Curated MONDO disease pages that list MTHFR among their top associated genes.

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.